MTI focuses its efforts in two under-served markets, the treatment of neurovascular disorders of the brain associated with stroke and the treatment of peripheral vascular disease, including blood clot therapy in hemodialysis access grafts, arteries and veins. The Company currently markets more than 130 products for the treatment of neuro and peripheral vascular disease. The primary users of MTI's products are interventional radiologists and neuroradiologists.
Revenues reflect strong sales in the neuro vascular product lines.
Lower loss was partially offset by costs associated with the sales force. Market Guide offers more in-depth Company Research , Stock Screening , and Hottest Stocks and Industries on over 10,000 U.S. Equities. All Rights Reserved. Privacy Policy - Terms of Service Company information Copyright Market Guide . Data and information is provided for informational purposes only, and is not intended for trading purposes.